Xu, Yuhai
Guo, Chaoping
Yong, Yan
Liu, Boyu
Guan, YongQing
Wang, Shengxiang
Zheng, Shubin
Zhao, Jingyu
Ji, Jun
Zhou, Xueyue
Funding for this research was provided by:
General Project of Science and Technology Boosting Program of Air Force Characteristic Medical Center (2022ZTYB45)
Article History
Received: 24 March 2025
Accepted: 10 March 2026
First Online: 17 April 2026
Declarations
:
: The authors declare no competing interests.
: This study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Ethics approval was provided by the Ethics Committee of Air Force Medical Center (Approval No. 2023-18-S01). Written informed consent was obtained from all participants.
: All animal protocols were approved by the Beijing Huafu Kang Biotechnology Co., Ltd. (Animal Quality Certificate No. SCXK 2004-0003). All animal experiments were carried out in accordance with relevant guidelines and regulations. All methods were reported in accordance with ARRIVE guidelines.